SCHEMBL20182298

SCHEMBL20182298

CC(/C(=C/Nc1ccc(F)cc1F)N=N)n1cc(-c2ccc(OC3CC3)nc2)c2c(N)ncnc21

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NEK7 Q8TDX7 12/20 0.38
NTRK1 P04629 1/20 0.38
NTRK3 Q16288 1/20 0.38
NTRK2 Q16620 1/20 0.38
EIF2AK3 Q9NZJ5 1/20 0.36
KCNH2 Q12809 1/20 0.35
KDR P35968 3/20 0.35
TEK Q02763 3/20 0.35
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
PIK3CG P48736 1/20 0.35
PRKDC P78527 1/20 0.35
LCK P06239 2/20 0.34
SRC P12931 1/20 0.34
RIPK2 O43353 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182200 0.93 KDR (0.39) NEK7EIF2AK3KCNH2KDRTEK
SCHEMBL20181883 0.86 NTRK1 (0.40) NEK7NTRK1NTRK3NTRK2EIF2AK3
SCHEMBL20182228 0.84 KDR (0.45) KDRTEKLCKSRCRIPK2
SCHEMBL20182231 0.81 NTRK1 (0.44) NEK7NTRK1NTRK3NTRK2EIF2AK3
SCHEMBL20181890 0.79 KDR (0.44) KDRTEKPIK3CDPIK3CAPIK3CB
SCHEMBL20182362 0.78 CFTR (0.40) KDRTEKPIK3CDPIK3CAPIK3CB
SCHEMBL20182294 0.78 CFTR (0.40) NEK7NTRK1NTRK3NTRK2EIF2AK3
SCHEMBL20182291 0.77 NTRK1 (0.38) NEK7NTRK1NTRK3NTRK2EIF2AK3
SCHEMBL20182292 0.77 NEK7 (0.37) NEK7NTRK1NTRK3NTRK2EIF2AK3
SCHEMBL20162918 0.75 CFTR (0.46) EIF2AK3KCNH2KDRTEKPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed